Related Experiment Video
Updated: Jul 30, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Long COVID Syndrome: A Case-Control Study
Rachel-Anne Xuereb1, Marica Borg2, Kevin Vella2
1Mater Dei Hospital, Msida, Malta; University of Malta Medical School, Msida.
Insights
Post-COVID-19 patients experience persistent symptoms and ongoing inflammation for months after infection. This study highlights medium-term cardiovascular sequelae and their association with inflammation markers like high-sensitivity C-reactive protein (hsCRP).
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Acute COVID-19 (coronavirus disease 2019) is linked to cardiovascular complications.
- Long-term cardiovascular effects post-COVID-19 remain largely unknown.
- Investigating medium-term sequelae is crucial for patient management.
Purpose of the Study:
- Assess symptomatology and health-related quality of life (HRQoL) at 6 months post-COVID-19.
- Determine if COVID-19 history and persistent shortness of breath correlate with inflammation, endothelial dysfunction, and cardiac injury.
- Evaluate ongoing systemic inflammation markers in post-COVID-19 patients.
Main Methods:
- Case-control study comparing 174 COVID-19 survivors with 75 age- and gender-matched controls.
- Interviews to assess symptoms and HRQoL using the Short Form Survey-36.
- Biochemical tests including high-sensitivity C-reactive protein (hsCRP), troponin I, and hemoglobin levels.
Main Results:
- COVID-19 survivors reported increased shortness of breath, fatigue, arthralgia, and altered taste/smell compared to controls.
- Cases showed significantly higher hsCRP levels, positively correlated with time post-infection.
- Persistent shortness of breath was associated with age, female gender, white cell count, troponin I, and lower hemoglobin.
Conclusions:
- Post-COVID-19 patients exhibit persistent symptoms at medium-term follow-up.
- Elevated hsCRP and its association with time indicate ongoing systemic inflammation for months.
- Findings suggest potential for medium-term cardiovascular sequelae requiring further investigation.
Background:
Acute coronavirus disease 2019 (COVID-19) causes various cardiovascular complications. However, it is unknown if there are cardiovascular sequelae in the medium and long-term. The aim of this study was dual. Firstly, we wanted to investigate symptomatology and health-related quality of life (HRQoL) at medium-term follow-up (6 months post-COVID). Secondly, we wanted to assess whether history of COVID-19 and persistent shortness of breath at medium-term follow-up are associated with ongoing inflammation, endothelial dysfunction, and cardiac injury.
Methods:
A case-control study was performed. Virologically proven COVID-19 cases and age- and gender-matched controls were interviewed to assess symptoms and HRQoL. Biochemical tests were also performed.
Results:
The study comprised 174 cases and 75 controls. The mean age of the participants was 46.1±13.8 years. The median follow-up was 173.5 days (interquartile range 129-193.25 days). There was no significant difference in the demographics between cases and controls. At follow-up, cases had a higher frequency of shortness of breath, fatigue, arthralgia, abnormal taste of food (P <.001), and anosmia. Cases also exhibited worse scores in the general health and role physical domains of the Short Form Survey-36. High-sensitivity C-reactive protein (hsCRP) was significantly higher in the cases, and there was a positive correlation of hsCRP with time. Significant determinants of shortness of breath were age, female gender and white cell count, troponin I, and lower hemoglobin levels at follow-up.
Conclusion:
Post-COVID-19 patients have persistent symptomatology at medium-term follow-up. Higher hsCRP in cases and the positive association of hsCRP with time suggest ongoing systemic inflammation in patients persisting for months after COVID-19.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Longitudinal Research
Controls in Experiments
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Bias in Epidemiological Studies